{
    "filename": "mm6909e1-H.pdf",
    "content_type": "application/pdf",
    "file_size": 72815,
    "metadata": {
        "identifiers": {
            "doi": "10.15585/mmwr.mm6909e1",
            "url": "https://www.cdc.gov/mmwr/volumes/69/wr/pdfs/mm6909e1-H.pdf"
        },
        "title": "Active Monitoring of Persons Exposed to Patients with Confirmed COVID-19 \u2014 United States, January\u2013February 2020",
        "keywords": [
            "Coronavirus Disease 2019",
            "COVID-19",
            "Active Monitoring 2019 Novel Coronavirus",
            "Coronavirus US",
            "Person-To-Person Transmission Of SARS-CoV-2"
        ],
        "date": 2020,
        "author": "Rachel M. Burke, Claire M. Midgley, Alissa Dratch, Marty Fenstersheib, Thomas Haupt, Michelle Holshue, Isaac Ghinai, M. Claire Jarashow, Jennifer Lo, Tristan D. McPherson, Sara Rudman, Sarah Scott, Aron J. Hall, Alicia M. Fry, Melissa A. Rolfes",
        "affiliations": [
            "US Department of Health and Human Services/Centers for Disease Control and Prevention"
        ],
        "journal": "MMWR. Morbidity and Mortality Weekly Report",
        "volume": "69",
        "abstract": "In December 2019, an outbreak of coronavirus disease 2019 (COVID-19), caused by the virus SARS-CoV-2, began in Wuhan, China (1). The disease spread widely in China, and, as of February 26, 2020, COVID-19 cases had been identified in 36 other countries and territories, including the United States. Person-to-person transmission has been widely documented, and a limited number of countries have reported sustained person-to-person spread.* On January 20, state and local health departments in the United States, in collaboration with teams deployed from CDC, began identifying and monitoring all persons considered to have had close contact\u2020 with patients with confirmed COVID-19 (2). The aims of these efforts were to ensure rapid evaluation and care of patients, limit further transmission, and better understand risk factors for transmission.",
        "references": "@book{disease2019a,\n  author = {disease, Coronavirus},\n  date = {2019},\n  title = {(COVID- 19): situation report \u2013 36},\n  publisher = {World Health Organization; 2020},\n  url = {https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200225-sitrep-36covid-19.pdf},\n  language = {},\n  address = {Geneva, Switzerland}\n}\n@article{patel2019a,\n  author = {Patel, A. and Jernigan, D.B.},\n  date = {2019-02-31},\n  title = {CDC Response Team. Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak\u2014United States},\n  journal = {MMWR Morb Mortal Wkly Rep},\n  volume = {2020},\n  pages = {140\u20136},\n  url = {https://doi.org/10.15585/mmwr.mm6905e1},\n  source = {4, 2020},\n  number = {69},\n  language = {}\n}\n",
        "links": [
            "https://www.cdc.gov/coronavirus/2019-ncov/infection-control/",
            "https://www.cdc.gov/coronavirus/2019-nCoV/hcp/clinical-criteria.html",
            "https://www.cdc.gov/",
            "https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-prevent-spread.html",
            "https://emergency.cdc.gov/han/2020/han00428.asp",
            "https://www.cdc.gov/coronavirus/2019-ncov/travelers/index.html",
            "https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-prevent-spread"
        ],
        "emails": [
            "lxx8@cdc.gov"
        ],
        "pages": "245-246",
        "references_ris": "TY  - BOOK\nAU  - disease, Coronavirus\nPY  - 2019\nDA  - 2019\nTI  - (COVID- 19): situation report \u2013 36\nPB  - World Health Organization; 2020\nUR  - https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200225-sitrep-36covid-19.pdf\nLA  - \nCY  - Geneva, Switzerland\nER  - \n\nTY  - JOUR\nAU  - Patel, A.\nAU  - Jernigan, D.B.\nPY  - 2019\nDA  - 2019/02/31\nTI  - CDC Response Team. Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak\u2014United States\nT2  - MMWR Morb Mortal Wkly Rep\nVL  - 2020\nSP  - 140\nEP  - 6\nUR  - https://doi.org/10.15585/mmwr.mm6905e1\nT2  - 4, 2020\nIS  - 69\nLA  - \nER  - \n\n",
        "author_conclusions": [],
        "table_captions": [],
        "figure_captions": []
    },
    "sections": {
        "acknowledgments": [
            "Maricopa County Department of Public Health; Arizona Department of Health Services; Lynn Mello, Mary White, Cynthia Marttila, Patricia Mottu-Monteon, Anthony Aguiar, Anita Alvarez, Veronica Guerra, San Benito County Public Health Services; Sara Cody, George Han, Shanon Smith, Elsa Villarino, Santa Clara County Public Health Department; Scott Lindquist, Washington State Department of Health; Hollianne Bruce, Snohomish Health District, Everett, Washington; Jeff Duchin, Vance Kawakami, Shauna Clark, Public Health Seattle-King County; Boston Public Health<br/><br/>Commission; Sharon Balter, Dawn Terashita, Prabhu Gounder, Zach Rubin, Rebecca Fisher, Chelsea Foo, Meredith Haddix, Elizabeth Traub, Rebecca Lee, Kelsey Oyong, Christina Eclarino, Keith Gurtzweiler, Jennifer Kilburn, Jan King, Lucille Rayford, Ashley Griffin, Los Angeles County Department of Public Health; Howard Chiou, Los Angeles County of Public Health and COVID-19 Response Team, CDC; Rebecca Sunenshine, Maricopa County Department of Public Health and COVID-19 Response Team, CDC. Olivia Almendares, Miwako Kobayashi, Olivia McGovern, Heather Reese, Anna Yousaf, Vaughn Barry, Karlyn Beer, Erin Conners, Connor Hoff, Allison Miller, Isaac Benowitz, Nora Chea, Cheri Grigg, Jennifer Hunter, Shannon Novosad, Amy Valderrama, Matthew Westercamp, Katie Wilson, Matthew Biggerstaff, Leora Feldstein, Pamela Kennedy, Archana Kumar, Holly Biggs, Jordan Cates, Victoria Chu, Nakia Clemmons, Brandi Freeman, Amber Haynes, Anita Kambhampati, Hannah Kirking, Stephen Lindstrom, Ruth Link-Gelles, Joana Lively, Mariel Marlow, Claire Mattison, Nancy McClung, Manisha Patel, Brian Rha, Janell Routh, Megan Wallace, John Watson, Kevin Chatham-Stephens, Max Cohen, Vishal Dasari, Matthew Donahue, Max Jacobs, Heather Rhodes, Varun Shetty, Amy Xie, Patrick Dawson, Jonathan Dyal, Mary Evans, Marc Fischer, Grace Vahey, Marie Killerby, Jennifer Verani, Kristen Pettrone, Satish Pillai, Sarah Elizabeth Smith-Jeffcoat, Bryan Stierman, Florence Whitehill, Jonathan Wortham, COVID-19 Response Team, CDC.<br/><br/>All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed."
        ],
        "data_availability": [
            "Further information is available at https://www.cdc.gov/coronavirus/2019-nCoV/hcp/clinical-criteria.html"
        ],
        "introduction": [
            "In December 2019, an outbreak of coronavirus disease 2019 (COVID-19), caused by the virus SARS-CoV-2, began in Wuhan, China (1). The disease spread widely in China, and, as of February 26, 2020, COVID-19 cases had been identified in 36 other countries and territories, including the United States. Person-to-person transmission has been widely documented, and a limited number of countries have reported sustained person-to-person spread.* On January 20, state and local health departments in the United States, in collaboration with teams deployed from CDC, began identifying and monitoring all persons considered to have had close contact\u2020 with patients with confirmed COVID-19 (2). The aims of these efforts were to ensure rapid evaluation and care of patients, limit further transmission, and better understand risk factors for transmission.",
            "As of February 26, 12 travel-related COVID-19 cases had been diagnosed in the United States, in addition to three COVID-19 cases in patients with no travel history (including two cases in close household contacts) and 46 cases reported among repatriated U.S citizens.\u00a7 Following confirmed diagnosis, the 12 patients with travel-related COVID-19 were isolated in the hospital if medically necessary, or at home once home care was deemed clinically sufficient.\u00b6 Among the first 10 patients with travel-related confirmed COVID-19 reported in the United States, a total of 445 persons (range = 1\u2013201 persons per case) who had close contact with one of the 10 patients on or after the date of the patient\u2019s symptom onset were identified. Nineteen (4%) of the 445 contacts were members of a patient\u2019s household, and five of these 19 contacts continued to have household exposure to the patient with confirmed COVID-19 during the patient\u2019s isolation period; 104 (23%) were community members who spent at least 10 minutes within 6 feet of a patient with confirmed disease; 100 (22%) were community"
        ]
    },
    "structured_content": {
        "Acknowledgments": [
            "Maricopa County Department of Public Health; Arizona Department of Health Services; Lynn Mello, Mary White, Cynthia Marttila, Patricia Mottu-Monteon, Anthony Aguiar, Anita Alvarez, Veronica Guerra, San Benito County Public Health Services; Sara Cody, George Han, Shanon Smith, Elsa Villarino, Santa Clara County Public Health Department; Scott Lindquist, Washington State Department of Health; Hollianne Bruce, Snohomish Health District, Everett, Washington; Jeff Duchin, Vance Kawakami, Shauna Clark, Public Health Seattle-King County; Boston Public Health",
            "Commission; Sharon Balter, Dawn Terashita, Prabhu Gounder, Zach Rubin, Rebecca Fisher, Chelsea Foo, Meredith Haddix, Elizabeth Traub, Rebecca Lee, Kelsey Oyong, Christina Eclarino, Keith Gurtzweiler, Jennifer Kilburn, Jan King, Lucille Rayford, Ashley Griffin, Los Angeles County Department of Public Health; Howard Chiou, Los Angeles County of Public Health and COVID-19 Response Team, CDC; Rebecca Sunenshine, Maricopa County Department of Public Health and COVID-19 Response Team, CDC. Olivia Almendares, Miwako Kobayashi, Olivia McGovern, Heather Reese, Anna Yousaf, Vaughn Barry, Karlyn Beer, Erin Conners, Connor Hoff, Allison Miller, Isaac Benowitz, Nora Chea, Cheri Grigg, Jennifer Hunter, Shannon Novosad, Amy Valderrama, Matthew Westercamp, Katie Wilson, Matthew Biggerstaff, Leora Feldstein, Pamela Kennedy, Archana Kumar, Holly Biggs, Jordan Cates, Victoria Chu, Nakia Clemmons, Brandi Freeman, Amber Haynes, Anita Kambhampati, Hannah Kirking, Stephen Lindstrom, Ruth Link-Gelles, Joana Lively, Mariel Marlow, Claire Mattison, Nancy McClung, Manisha Patel, Brian Rha, Janell Routh, Megan Wallace, John Watson, Kevin Chatham-Stephens, Max Cohen, Vishal Dasari, Matthew Donahue, Max Jacobs, Heather Rhodes, Varun Shetty, Amy Xie, Patrick Dawson, Jonathan Dyal, Mary Evans, Marc Fischer, Grace Vahey, Marie Killerby, Jennifer Verani, Kristen Pettrone, Satish Pillai, Sarah Elizabeth Smith-Jeffcoat, Bryan Stierman, Florence Whitehill, Jonathan Wortham, COVID-19 Response Team, CDC.",
            "All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed."
        ],
        "References": [
            "1. Coronavirus disease. 2019 (COVID-19): situation report \u2013 36. Geneva, Switzerland: World Health Organization; 2020. https://www.who.int/ docs/default-source/coronaviruse/situation-reports/20200225-sitrep-36covid-19.pdf?sfvrsn=2791b4e0_2",
            "2. <a class=\"ref-link\" id=\"cPatel_2019_a\" href=\"#rPatel_2019_a\">Patel A, Jernigan DB; 2019</a>-nCoV CDC Response Team. Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak\u2014United States, December 31, 2019\u2013February 4, 2020. MMWR Morb Mortal Wkly Rep 2020;69:140\u20136. https://doi.org/10.15585/mmwr. mm6905e1"
        ]
    },
    "participants": [
        {
            "participant": "cases",
            "number": 46,
            "context": "The aims of these efforts were to ensure rapid evaluation and care of patients, limit further transmission, and better understand risk factors for transmission. <mark class=\"stats\">As of February 26, 12 travel-related COVID-19 cases had been diagnosed in the United States, in addition to three COVID-19 cases in patients with no travel history (including two cases in close household contacts) and 46 cases reported among repatriated U.S citizens.\u00a7 Following confirmed diagnosis, the 12 patients with travel-related COVID-19 were isolated in the hospital if medically necessary, or at home once home care was deemed clinically sufficient.\u00b6 Among the first 10 patients with travel-related confirmed COVID-19 reported in the United States, a total of 445 persons (range = 1\u2013201 persons per case) who had close contact with one of the 10 patients on or after the date of the patient\u2019s symptom onset were identified</mark>. Nineteen (4%) of the 445 contacts were members of a patient\u2019s household, and five of these 19 contacts continued to have household exposure to the patient with confirmed COVID-19 during the patient\u2019s isolation period; 104 (23%) were community members who spent at least 10 minutes within 6 feet of a patient with confirmed disease; 100 (22%) were community"
        },
        {
            "participant": "contacts",
            "number": 445,
            "context": "As of February 26, 12 travel-related COVID-19 cases had been diagnosed in the United States, in addition to three COVID-19 cases in patients with no travel history (including two cases in close household contacts) and 46 cases reported among repatriated U.S citizens.\u00a7 Following confirmed diagnosis, the 12 patients with travel-related COVID-19 were isolated in the hospital if medically necessary, or at home once home care was deemed clinically sufficient.\u00b6 Among the first 10 patients with travel-related confirmed COVID-19 reported in the United States, a total of 445 persons (range = 1\u2013201 persons per case) who had close contact with one of the 10 patients on or after the date of the patient\u2019s symptom onset were identified. <mark class=\"stats\">Nineteen (4%) of the 445 contacts were members of a patient\u2019s household, and five of these 19 contacts continued to have household exposure to the patient with confirmed COVID-19 during the patient\u2019s isolation period; 104 (23%) were community members who spent at least 10 minutes within 6 feet of a patient with confirmed disease; 100 (22%) were community</mark>. * https://www.cdc.gov/coronavirus/2019-ncov/travelers/index.html. \u2020 Close contact was defined by the state and local health jurisdictions with reference to the following online guidance: https://www.cdc.gov/ coronavirus/2019-ncov/hcp/guidance-risk-assesment-hcp.html. \u00a7 https://emergency.cdc.gov/han/2020/han00428.asp. \u00b6 https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-prevent-spread.html"
        },
        {
            "participant": "persons",
            "number": 2,
            "context": "During the 14 days of active symptom monitoring, 54 (12%) close contacts developed new or worsening symptoms deemed by local public health authorities to be concerning for COVID-19 and were thus considered persons under investigation (PUIs)\u00a7\u00a7 and subsequently were tested for SARS-CoV-2. <mark class=\"stats\">Two persons who were household members of patients with confirmed COVID-19 tested positive for SARS-CoV-2</mark>. This yielded a symptomatic secondary attack rate of 0.45% (95% confidence interval [CI] = 0.12%\u20131.6%) among all close contacts,\u00b6\u00b6 and a symptomatic secondary attack rate of 10.5% (95% CI = 2.9%\u201331.4%) among household members"
        },
        {
            "participant": "household members",
            "number": 5,
            "context": "was confirmed and were isolated from the source patient after the patient\u2019s COVID-19 diagnosis. <mark class=\"stats\">No other close contacts who were tested for SARS-CoV-2 had a positive test, including the five household members who were continuously exposed during the period of isolation of their household member with confirmed COVID-19</mark>. An additional 146 persons exposed to the two patients with secondary COVID-19 transmission underwent 14 days of active monitoring"
        },
        {
            "participant": "patients with secondary COVID-19 transmission underwent 14 days of",
            "number": 2,
            "context": "No other close contacts who were tested for SARS-CoV-2 had a positive test, including the five household members who were continuously exposed during the period of isolation of their household member with confirmed COVID-19. <mark class=\"stats\">An additional 146 persons exposed to the two patients with secondary COVID-19 transmission underwent 14 days of active monitoring</mark>. Among these, 18 (12%) developed symptoms compatible with COVID-19 and were considered PUIs"
        },
        {
            "participant": "persons with diagnosed travel-related COVID-19",
            "number": 10,
            "context": "Since February 28, an increasing number of newly diagnosed confirmed and presumptive COVID-19 cases have been in patients with neither a relevant travel history nor clear epidemiologic links to other confirmed COVID-19 patients. <mark class=\"stats\">However, despite intensive follow-up, no sustained person-to-person transmission of symptomatic SARS-CoV-2 was observed in the United States among the close contacts of the first 10 persons with diagnosed travel-related COVID-19</mark>. Analyses of timing of exposure during each patient\u2019s illness as well as the type and duration of exposures will provide information on potential risk factors for transmission"
        }
    ],
    "statistics": [],
    "keywords": [
        "limited number",
        "Coronavirus Disease 2019",
        "Person-To-Person Transmission Of SARS-CoV-2",
        "Active Monitoring 2019 Novel Coronavirus",
        "coronavirus disease",
        "Coronavirus US",
        "person transmission",
        "virus sars cov",
        "united states",
        "close contact\u2020",
        "active monitoring",
        "COVID-19",
        "persons under investigation",
        "local health department",
        "rapid evaluation",
        "sustained person",
        "risk factor"
    ],
    "keyword_relevance": {
        "COVID-19": 0.6666666666666666,
        "persons under investigation": 0.0784313725490196,
        "person transmission": 0.058823529411764705,
        "sustained person": 0.0392156862745098,
        "risk factor": 0.0392156862745098,
        "limited number": 0.0196078431372549,
        "coronavirus disease": 0.0196078431372549,
        "close contact\u2020": 0.0196078431372549,
        "active monitoring": 0.0196078431372549,
        "local health department": 0.0196078431372549,
        "rapid evaluation": 0.0196078431372549,
        "Coronavirus Disease 2019": 0.0,
        "Person-To-Person Transmission Of SARS-CoV-2": 0.0,
        "Active Monitoring 2019 Novel Coronavirus": 0.0,
        "Coronavirus US": 0.0,
        "virus sars cov": 0.0,
        "united states": 0.0
    },
    "species": [],
    "summary": [
        "In December 2019, an outbreak of coronavirus disease 2019 (COVID-19), caused by the virus SARS-CoV-2, began in Wuhan, China (1).",
        "* https://www.cdc.gov/coronavirus/2019-ncov/travelers/index.html.",
        "\u2020 Close contact was defined by the state and local health jurisdictions with reference to the following online guidance: https://www.cdc.gov/ coronavirus/2019-ncov/hcp/guidance-risk-assesment-hcp.html.",
        "\u00b6 https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-prevent-spread.html.",
        "Active symptom monitoring of the 445 close contacts, consisting of daily telephone, text, or in-person inquiries about fever or other symptoms for 14 days following the last known exposure to a person with confirmed COVID-19, was conducted by local health jurisdictions.",
        "During the 14 days of active symptom monitoring, 54 (12%) close contacts developed new or worsening symptoms deemed by local public health authorities to be concerning for COVID-19 and were considered persons under investigation (PUIs)\u00a7\u00a7 and subsequently were tested for SARS-CoV-2.",
        "Two persons who were household members of patients with confirmed COVID-19 tested positive for SARS-CoV-2.",
        "Both persons with confirmed secondary transmission had close contact with the respective source patient before COVID-19",
        "** For these investigations, exposure of community members within a health care setting was defined as either at least 10 minutes spent within 6 feet of the patient with confirmed COVID-19 or having spent time in the same airspace for 0\u20132 hours after the confirmed COVID-19 patient.",
        "\u00a7\u00a7 At the time of the investigations, persons with close contact to a confirmed COVID-19 patient could be considered PUIs if they developed fever or signs or symptoms of lower respiratory tract illness.",
        "Symptomatic close contacts of a patient with confirmed COVID-19 should be further evaluated in consultation with public health authorities to review signs or symptoms and possible exposure on a case-by-case basis.",
        "Further information is available at https://www.cdc.gov/coronavirus/2019-nCoV/hcp/clinical-criteria.html.",
        "No other close contacts who were tested for SARS-CoV-2 had a positive test, including the five household members who were continuously exposed during the period of isolation of their household member with confirmed COVID-19.",
        "In the United States, two instances of person-to-person transmission of SARS-CoV-2 have been documented from persons with travel-related COVID-19 to their household contacts.",
        "Despite intensive follow-up, no sustained person-to-person transmission of symptomatic SARS-CoV-2 was observed in the United States among the close contacts of the first 10 persons with diagnosed travel-related COVID-19.",
        "Infection control and prevention efforts by patients with COVID-19, their household members, and their health care providers,*** in combination with contact tracing activities, are important to mitigate community spread of the disease.",
        "*** https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-prevent-spread."
    ],
    "structured_summary": {
        "Introduction": [
            "In December 2019, an outbreak of coronavirus disease 2019 (COVID-19), caused by the virus SARS-CoV-2, began in Wuhan, China (1).",
            "* https://www.cdc.gov/coronavirus/2019-ncov/travelers/index.html.",
            "\u2020 Close contact was defined by the state and local health jurisdictions with reference to the following online guidance: https://www.cdc.gov/ coronavirus/2019-ncov/hcp/guidance-risk-assesment-hcp.html."
        ],
        "Results": [
            "\u00b6 https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-prevent-spread.html.",
            "Active symptom monitoring of the 445 close contacts, consisting of daily telephone, text, or in-person inquiries about fever or other symptoms for 14 days following the last known exposure to a person with confirmed COVID-19, was conducted by local health jurisdictions.",
            "During the 14 days of active symptom monitoring, 54 (12%) close contacts developed new or worsening symptoms deemed by local public health authorities to be concerning for COVID-19 and were considered persons under investigation (PUIs)\u00a7\u00a7 and subsequently were tested for SARS-CoV-2.",
            "Two persons who were household members of patients with confirmed COVID-19 tested positive for SARS-CoV-2.",
            "Both persons with confirmed secondary transmission had close contact with the respective source patient before COVID-19",
            "** For these investigations, exposure of community members within a health care setting was defined as either at least 10 minutes spent within 6 feet of the patient with confirmed COVID-19 or having spent time in the same airspace for 0\u20132 hours after the confirmed COVID-19 patient.",
            "\u00a7\u00a7 At the time of the investigations, persons with close contact to a confirmed COVID-19 patient could be considered PUIs if they developed fever or signs or symptoms of lower respiratory tract illness.",
            "Symptomatic close contacts of a patient with confirmed COVID-19 should be further evaluated in consultation with public health authorities to review signs or symptoms and possible exposure on a case-by-case basis.",
            "Further information is available at https://www.cdc.gov/coronavirus/2019-nCoV/hcp/clinical-criteria.html.",
            "No other close contacts who were tested for SARS-CoV-2 had a positive test, including the five household members who were continuously exposed during the period of isolation of their household member with confirmed COVID-19.",
            "In the United States, two instances of person-to-person transmission of SARS-CoV-2 have been documented from persons with travel-related COVID-19 to their household contacts."
        ],
        "Conclusion": [
            "Despite intensive follow-up, no sustained person-to-person transmission of symptomatic SARS-CoV-2 was observed in the United States among the close contacts of the first 10 persons with diagnosed travel-related COVID-19.",
            "Infection control and prevention efforts by patients with COVID-19, their household members, and their health care providers,*** in combination with contact tracing activities, are important to mitigate community spread of the disease.",
            "*** https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-prevent-spread."
        ]
    },
    "reference_links": [
        {
            "id": "1",
            "alt_id": "Disease_2019_a",
            "entry": "1. Coronavirus disease. 2019 (COVID-19): situation report \u2013 36. Geneva, Switzerland: World Health Organization; 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200225-sitrep-36covid-19.pdf?sfvrsn=2791b4e0_2",
            "url": "https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200225-sitrep-36covid-19.pdf?sfvrsn=2791b4e0_2"
        },
        {
            "id": "2",
            "alt_id": "Patel_2019_a",
            "entry": "2. Patel A, Jernigan DB; 2019-nCoV CDC Response Team. Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak\u2014United States, December 31, 2019\u2013February 4, 2020. MMWR Morb Mortal Wkly Rep 2020;69:140\u20136. https://doi.org/10.15585/mmwr.mm6905e1 ",
            "crossref": "https://dx.doi.org/10.15585/mmwr.mm6905e1",
            "scite": "https://scite.ai/reports/10.15585/mmwr.mm6905e1",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=https%3A//dx.doi.org/10.15585/mmwr.mm6905e1"
        }
    ],
    "facts": [
        "COVID-19 cases had been identified in 36 other countries and territories",
        "in collaboration with teams deployed from CDC",
        "12 travel-related COVID-19 cases had been diagnosed in the United States",
        "46 cases reported among repatriated U.S citizens.\u00a7 Following confirmed diagnosis",
        "the 12 patients with travel-related COVID-19 were isolated in the hospital",
        "10 patients with travel-related confirmed COVID-19 reported in the United States",
        "\u2020 Close contact was defined by the state",
        "worsening symptoms deemed by local public health authorities to be concerning for",
        "Two persons who were household members of patients with confirmed COVID-19 tested positive for SARS-CoV-2",
        "least 10 minutes spent within 6 feet of the patient",
        "Symptomatic close contacts of a patient with confirmed COVID-19 should be further evaluated in consultation with public health authorities to review signs or symptoms",
        "Further information is available at https://www.cdc.gov/coronavirus/2019-nCoV/hcp/clinical-criteria.html",
        "No other close contacts who were tested for SARS-CoV-2 had a positive test",
        "the five household members who were continuously exposed during the period of isolation",
        "two instances of person-to-person transmission of SARS-CoV-2 have been documented from persons with travel-related COVID-19",
        "no sustained person-to-person transmission of symptomatic SARS-CoV-2 was observed in the United States among the close contacts",
        "mitigate community spread of the disease"
    ],
    "claims": [],
    "findings": [
        "Two persons who were household members of patients with confirmed COVID-19 tested positive for SARS-CoV-2. This yielded a symptomatic secondary attack rate of 0.45% (95% confidence interval [CI] = 0.12%\u20131.6%) among all close contacts,\u00b6\u00b6 and a symptomatic secondary attack rate of 10.5% (95% CI = 2.9%\u201331.4%) among household members"
    ],
    "processes": [],
    "key_statements": [
        "As of February 26, 12 travel-related COVID-19 cases had been diagnosed in the United States, in addition to three COVID-19 cases in patients with no travel history and 46 cases reported among repatriated U.S citizens.\u00a7 Following confirmed diagnosis, the 12 patients with travel-related COVID-19 were isolated in the hospital if medically necessary, or at home once home care was deemed clinically sufficient.\u00b6 Among the first 10 patients with travel-related confirmed COVID-19 reported in the United States, a total of 445 persons who had close contact with one of the 10 patients on or after the date of the patient\u2019s symptom onset were identified",
        "During the 14 days of active symptom monitoring, 54 (12%) close contacts developed new or worsening symptoms deemed by local public health authorities to be concerning for COVID-19 and were considered persons under investigation (PUIs)\u00a7\u00a7 and subsequently were tested for SARS-CoV-2",
        "In the United States, two instances of person-to-person transmission of SARS-CoV-2 have been documented from persons with travel-related COVID-19 to their household contacts",
        "Two persons who were household members of patients with confirmed COVID-19 tested positive for SARS-CoV-2. This yielded a symptomatic secondary attack rate of 0.45% (95% confidence interval [CI] = 0.12%\u20131.6%) among all close contacts,\u00b6\u00b6 and a symptomatic secondary attack rate of 10.5% (95% CI = 2.9%\u201331.4%) among household members",
        "Despite intensive follow-up, no sustained person-to-person transmission of symptomatic SARS-CoV-2 was observed in the United States among the close contacts of the first 10 persons with diagnosed travel-related COVID-19"
    ],
    "top_statements": [
        "In December 2019, an outbreak of coronavirus disease 2019 (COVID-19), caused by the virus SARS-CoV-2, began in Wuhan, China (1)",
        "As of February 26, 12 travel-related COVID-19 cases had been diagnosed in the United States, in addition to three COVID-19 cases in patients with no travel history and 46 cases reported among repatriated U.S citizens.\u00a7 Following confirmed diagnosis, the 12 patients with travel-related COVID-19 were isolated in the hospital if medically necessary, or at home once home care was deemed clinically sufficient.\u00b6 Among the first 10 patients with travel-related confirmed COVID-19 reported in the United States, a total of 445 persons who had close contact with one of the 10 patients on or after the date of the patient\u2019s symptom onset were identified",
        "During the 14 days of active symptom monitoring, 54 (12%) close contacts developed new or worsening symptoms deemed by local public health authorities to be concerning for COVID-19 and were considered persons under investigation (PUIs)\u00a7\u00a7 and subsequently were tested for SARS-CoV-2",
        "In the United States, two instances of person-to-person transmission of SARS-CoV-2 have been documented from persons with travel-related COVID-19 to their household contacts",
        "Two persons who were household members of patients with confirmed COVID-19 tested positive for SARS-CoV-2. This yielded a symptomatic secondary attack rate of 0.45% (95% confidence interval [CI] = 0.12%\u20131.6%) among all close contacts,\u00b6\u00b6 and a symptomatic secondary attack rate of 10.5% (95% CI = 2.9%\u201331.4%) among household members",
        "Despite intensive follow-up, no sustained person-to-person transmission of symptomatic SARS-CoV-2 was observed in the United States among the close contacts of the first 10 persons with diagnosed travel-related COVID-19"
    ],
    "headline": "As of February 26, 12 travel-related COVID-19 cases had been diagnosed in the United States, in addition to three COVID-19 cases in patients with no travel history and 46 cases reported among repatriated U.S citizens.\u00a7 Following confirmed diagnosis, the 12 patients with travel-related COVID-19 were isolated in the hospital if medically necessary, or at home once home care was deemed clinically sufficient.\u00b6 Among the first 10 patients with travel-related confirmed COVID-19 reported in the United States, a total of 445 persons who had close contact with one of the 10 patients on or after the date of the patient\u2019s symptom onset were identified",
    "contexts": [],
    "abbreviations": {
        "PUIs": "persons under investigation"
    }
}
